Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phosphopyruvate hydratase activity	ENO1 ENO2 ENO3	2.86e-06	4	180	3	GO:0004634
GeneOntologyCellularComponent	phosphopyruvate hydratase complex	ENO1 ENO2 ENO3	2.29e-06	4	175	3	GO:0000015
GeneOntologyCellularComponent	ER membrane insertion complex	UBL4A NOMO1 NOMO2 NOMO3	4.45e-06	14	175	4	GO:0072379
GeneOntologyCellularComponent	cell cortex	SHROOM3 SPIRE2 SPTA1 PCLO ITGB4 KIAA1614 GRIP1 DLC1 ASPH ARC ENO1 ENO2 FCHSD1	1.55e-05	371	175	13	GO:0005938
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	4.67e-05	9	175	3	GO:0160064
GeneOntologyCellularComponent	axon	CACNA1B MAPK8IP1 CAD GIT1 SPTA1 PCLO INSRR LMTK2 PLXND1 SLC30A3 GRIP1 RNF6 NETO1 SCN3A KCNQ2 ALCAM ENO1 ENO2 HSPB1	1.78e-04	891	175	19	GO:0030424
GeneOntologyCellularComponent	lamellipodium membrane	NCKAP1 PLXND1 EPHA2	7.90e-04	22	175	3	GO:0031258
GeneOntologyCellularComponent	membrane raft	CHRNB2 GRIP1 CAVIN4 MYOF DLC1 ARC CAVIN1 ADAM17 ENO1 ENO2	9.81e-04	362	175	10	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	CHRNB2 GRIP1 CAVIN4 MYOF DLC1 ARC CAVIN1 ADAM17 ENO1 ENO2	1.02e-03	364	175	10	GO:0098857
GeneOntologyCellularComponent	focal adhesion	RPLP0 NCKAP1 GIT1 ARHGAP26 ITGB4 DLC1 EPHA2 ADAM17 ALCAM HSPB1 ALOX15B	1.05e-03	431	175	11	GO:0005925
GeneOntologyCellularComponent	cell-substrate junction	RPLP0 NCKAP1 GIT1 ARHGAP26 ITGB4 DLC1 EPHA2 ADAM17 ALCAM HSPB1 ALOX15B	1.31e-03	443	175	11	GO:0030055
GeneOntologyCellularComponent	hippocampal mossy fiber	MAPK8IP1 SLC30A3	1.42e-03	7	175	2	GO:0097457
Domain	Enolase_N	ENO1 ENO2 ENO3	8.51e-07	3	178	3	PF03952
Domain	Enolase	ENO1 ENO2 ENO3	8.51e-07	3	178	3	IPR000941
Domain	Enolase_C	ENO1 ENO2 ENO3	8.51e-07	3	178	3	IPR020810
Domain	Enolase_N	ENO1 ENO2 ENO3	8.51e-07	3	178	3	IPR020811
Domain	Enolase_CS	ENO1 ENO2 ENO3	8.51e-07	3	178	3	IPR020809
Domain	Enolase_C	ENO1 ENO2 ENO3	8.51e-07	3	178	3	PF00113
Domain	Enolase_N	ENO1 ENO2 ENO3	8.51e-07	3	178	3	SM01193
Domain	Enolase_C	ENO1 ENO2 ENO3	8.51e-07	3	178	3	SM01192
Domain	ENOLASE	ENO1 ENO2 ENO3	8.51e-07	3	178	3	PS00164
Domain	-	ENO1 ENO2 ENO3	3.38e-06	4	178	3	3.30.390.10
Domain	DUF2012	NOMO1 NOMO2 NOMO3	3.38e-06	4	178	3	PF09430
Domain	-	ENO1 ENO2 ENO3	3.38e-06	4	178	3	3.20.20.120
Domain	Enolase_C-like	ENO1 ENO2 ENO3	3.38e-06	4	178	3	IPR029065
Domain	DUF2012	NOMO1 NOMO2 NOMO3	3.38e-06	4	178	3	IPR019008
Domain	Enolase_N-like	ENO1 ENO2 ENO3	3.38e-06	4	178	3	IPR029017
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	4.60e-05	8	178	3	IPR013784
Domain	RBB1NT	ARID4B ARID4A	9.03e-05	2	178	2	PF08169
Domain	RBB1NT	ARID4B ARID4A	9.03e-05	2	178	2	IPR012603
Domain	PDEase_PDE8	PDE8A PDE8B	9.03e-05	2	178	2	IPR013938
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	2.27e-04	13	178	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	2.27e-04	13	178	3	2.60.40.1120
Domain	DUF1777	RBM26 DHX8	2.69e-04	3	178	2	IPR013957
Domain	-	ARID4B ARID4A ARID5B	3.56e-04	15	178	3	1.10.150.60
Domain	BRIGHT	ARID4B ARID4A ARID5B	3.56e-04	15	178	3	SM00501
Domain	ARID_dom	ARID4B ARID4A ARID5B	3.56e-04	15	178	3	IPR001606
Domain	ARID	ARID4B ARID4A ARID5B	3.56e-04	15	178	3	PS51011
Domain	ARID	ARID4B ARID4A ARID5B	3.56e-04	15	178	3	PF01388
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	5.25e-04	17	178	3	IPR008969
Domain	Cavin_fam	CAVIN4 CAVIN1	5.35e-04	4	178	2	IPR026752
Domain	PTRF_SDPR	CAVIN4 CAVIN1	5.35e-04	4	178	2	PF15237
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCC3 ABCC4 MAN2A2 MBOAT7 TUT7 SPCS2 RNF213 PLXND1 ITGB4 BTN2A1 NOMO1 MYOF CELSR1 HEG1 NOMO2 MICAL2 EPHA2 FHOD1 LPL ASPH LTBP1 ADAM17 TYW1 ALCAM EIF4G3	5.75e-09	1201	184	25	35696571
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 SHROOM3 SPIRE2 LRFN1 MAN2A2 ARHGAP26 LMTK2 UBL4A PLXND1 EDC4 TMEM127 ITGB4 REXO1 MYOF CELSR1 HEG1 MDN1 NFATC1 ARC KCNQ2 POLL BRAT1 RGL2	2.47e-08	1105	184	23	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 SHROOM3 SPIRE2 HIPK4 NCKAP1 GIT1 LSG1 LMTK2 ALPK1 EDC4 TRIP12 GRIP1 DLC1 MDN1 KIAA1217 EIF4G3 RGL2 UTRN DOP1B ZC3HAV1	3.70e-08	861	184	20	36931259
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	5.22e-08	8	184	4	12634303
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	1.46e-07	3	184	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	1.46e-07	3	184	3	25576386
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	MYCN ARID4B NCKAP1 ARID4A CHAF1A COPB2 RBM26 NPAS3 E4F1 PRC1 TRIP12 FOXR2 MDN1 NFATC1 TSHZ1 KDM1B PRDM15 NBR1 ANKRD20A1	1.70e-07	857	184	19	25609649
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 FUT10 ABCC4 SHROOM3 DNAJC13 JADE2 ST7 RNF213 KCNIP2 NFATC1 NETO1 MICAL2 KIAA1217 ZFP64 ASPH ARID5B CHD6 ALCAM EIF4G3 POLK ARHGEF26 PRDM15 UTRN NBR1 ZC3HAV1	3.54e-07	1489	184	25	28611215
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	DNAJC13 GIT1 LSG1 DDX60 COPB2 DVL3 PRC1 CPED1 TRIP12 DHX8 MYOF EPHA2 BRD9 MARF1 CAVIN1 EIF4G3 ZC3HAV1	3.55e-07	724	184	17	36232890
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	CACNA1B SHROOM3 DNAJC13 CAD NCKAP1 MAGIX PCLO TUT7 DVL3 FER1L4 ASPH ARID5B CAVIN1 MGAM2	4.65e-07	496	184	14	31343991
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RALGAPA1 ABCC4 DNAJC13 PDE8A MBOAT7 ST7 VPS8 ZFYVE9 COG6 EPHA2 ADAM17 TYW1 DOP1B ZC3HAV1	5.62e-07	504	184	14	34432599
Pubmed	A Moonlighting Human Protein Is Involved in Mitochondrial Import of tRNA.	ENO1 ENO2 ENO3	5.80e-07	4	184	3	25918939
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	5.80e-07	4	184	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	5.80e-07	4	184	3	9267806
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	NCKAP1 MBOAT7 TUT7 C1orf43 COPB2 SPCS2 NUP88 ELP1 UBL4A EDC4 TMEM127 TRIP12 EPHA2 ASPH EIF4G3 BRAT1 NBR1 HSPB1 NOMO3	7.07e-07	942	184	19	31073040
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1B MAPK8IP1 CAD RPLP0 HECW1 NCKAP1 GIT1 MBOAT7 PCLO COPB2 NUP88 DVL3 LMTK2 EDC4 ATE1 KIAA1217 SPHKAP KCNQ2 EIF4G3 ENO1 HSPB1	7.59e-07	1139	184	21	36417873
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	CAD RPLP0 DDX60 ARHGAP26 TRIP12 MYOF MDN1 NFATC1 MARF1 ENO1	2.10e-06	272	184	10	31010829
Pubmed	Cathepsin X cleaves the C-terminal dipeptide of alpha- and gamma-enolase and impairs survival and neuritogenesis of neuronal cells.	ENO1 ENO2 ENO3	2.88e-06	6	184	3	19433310
Pubmed	Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.	GIT1 ITGB4 EPHA2 CAVIN1 ENO1 ENO2	3.01e-06	75	184	6	15951569
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYCN DNAJC13 ARID4B RPLP0 GIT1 ARID4A CHAF1A TRIP12 REXO1 MYOF CCNYL1 MDN1 FHOD1 ASPH HSPB1 ZC3HAV1	4.09e-06	774	184	16	15302935
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	ABCC4 DNAJC13 LRFN1 GIT1 C1orf43 DVL3 USP25 ELP1 PDE8B ARID5B LTBP1	6.12e-06	378	184	11	34315543
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	8.00e-06	8	184	3	15257293
Pubmed	Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.	TMEM127 NOMO1 NOMO2 CHP2 MARF1 NOMO3	9.88e-06	92	184	6	10493829
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	CAD RPLP0 NCKAP1 TUT7 COPB2 NUP88 ELP1 EDC4 TRIP12 DHX8 MDN1 EIF4G3 UTRN ZC3HAV1	1.11e-05	653	184	14	22586326
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	1.20e-05	9	184	3	36261522
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RALGAPA1 SHROOM3 DNAJC13 CAD EAPP RPLP0 CENPC MBOAT7 LSG1 ST7 C1orf43 ELP1 UBL4A NOMO1 MDN1 NOMO2 EPHA2 ASPH TYW1 EIF4G3 NBR1 ZC3HAV1	1.40e-05	1487	184	22	33957083
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAPK8IP1 SHROOM3 DNAJC13 LRFN1 CAD HECW1 NCKAP1 GIT1 LSG1 EDC4 MDN1 NETO1 KIAA1217 SPHKAP ARC ARHGEF26 ENO1	1.59e-05	963	184	17	28671696
Pubmed	Nomenclature of the ARID family of DNA-binding proteins.	ARID4B ARID4A ARID5B	1.70e-05	10	184	3	15922553
Pubmed	Functional proteomics mapping of a human signaling pathway.	RPLP0 VPS8 DVL3 USP25 E4F1 TRIP12 NOMO1 GRIP1 MTMR11 ZFYVE9 CHD6 UTRN NOMO3	1.77e-05	591	184	13	15231748
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MYCN SPIRE2 RPLP0 CENPC ST7 CHAF1A RBM26 MDN1 NFATC1 BRD9 ENO1 PRDM15 HSPB1 RAD17	2.02e-05	689	184	14	36543142
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	2.33e-05	11	184	3	32820719
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DNHD1 CAD RPLP0 NCKAP1 LSG1 CHAF1A PCLO COPB2 RBM26 NUP88 ELP1 EDC4 PRC1 DHX8 NOMO1 MDN1 ENO1 NBR1 HSPB1 MGAM2 ZC3HAV1	2.35e-05	1425	184	21	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RALGAPA1 MAPK8IP1 DNAJC13 CAD RPLP0 NCKAP1 GIT1 MBOAT7 SPTA1 ARHGAP26 PCLO COPB2 ELP1 EDC4 MICAL2 KIAA1217 KCNQ2 EIF4G3 ENO2 UTRN HSPB1	2.50e-05	1431	184	21	37142655
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	CAD RPLP0 GIT1 LSG1 TUT7 NUP88 LMTK2 ELP1 PRC1 TRIP12 ZC3HAV1	2.51e-05	440	184	11	34244565
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	ARID4B ARID4A NUP88 E4F1 LTBP1 HSPB1	2.74e-05	110	184	6	26841866
Pubmed	cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis.	PDE8A PDE8B	2.78e-05	2	184	2	22232524
Pubmed	Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.	ENO1 ENO2	2.78e-05	2	184	2	30779465
Pubmed	Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development.	ENO1 ENO3	2.78e-05	2	184	2	2090519
Pubmed	The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland.	PDE8A PDE8B	2.78e-05	2	184	2	21187369
Pubmed	Analysis of specialized DNA polymerases expression in human gliomas: association with prognostic significance.	POLL POLK	2.78e-05	2	184	2	20164241
Pubmed	MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes.	CAVIN4 CAVIN1	2.78e-05	2	184	2	19546242
Pubmed	Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes.	ARID4B ARID4A	2.78e-05	2	184	2	18728284
Pubmed	HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages.	ENO1 ENO2	2.78e-05	2	184	2	17922513
Pubmed	CircKDM1B promotes hepatocellular carcinoma progression through regulating miR-1322/PRC1 axis.	PRC1 KDM1B	2.78e-05	2	184	2	37227723
Pubmed	Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans.	PDE8A PDE8B	2.78e-05	2	184	2	12681444
Pubmed	A non-canonical role for the EDC4 decapping factor in regulating MARF1-mediated mRNA decay.	EDC4 MARF1	2.78e-05	2	184	2	32510323
Pubmed	The molecular cloning and characterization of potential chick DM-GRASP homologs in zebrafish and mouse.	TCF19 ALCAM	2.78e-05	2	184	2	8089660
Pubmed	Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.	ADAM17 ALCAM	2.78e-05	2	184	2	20180536
Pubmed	cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor.	PDE8A PDE8B	2.78e-05	2	184	2	36277728
Pubmed	Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain.	ENO1 ENO2	2.78e-05	2	184	2	2362815
Pubmed	Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases.	ENO1 ENO2	2.78e-05	2	184	2	22551201
Pubmed	Complete structure of the human gene encoding neuron-specific enolase.	ENO1 ENO2	2.78e-05	2	184	2	2045099
Pubmed	Oral availability of cefadroxil depends on ABCC3 and ABCC4.	ABCC3 ABCC4	2.78e-05	2	184	2	22166395
Pubmed	Analysis of the cytoprotective role of α-crystallins in cell survival and implication of the αA-crystallin C-terminal extension domain in preventing Bax-induced apoptosis.	CRYAA RPE65	2.78e-05	2	184	2	23383327
Pubmed	FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling.	FHOD1 HSPB1	2.78e-05	2	184	2	37211949
Pubmed	The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.	ADAM17 ALCAM	2.78e-05	2	184	2	18171982
Pubmed	Neuroblastoma: a single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors.	MYCN ENO2	2.78e-05	2	184	2	11881792
Pubmed	Isolation of murine neuron-specific and non-neuronal enolase cDNA clones.	ENO1 ENO2	2.78e-05	2	184	2	3801001
Pubmed	A reduced zinc diet or zinc transporter 3 knockout attenuate light induced zinc accumulation and retinal degeneration.	SLC30A3 RPE65	2.78e-05	2	184	2	23274584
Pubmed	Biochemical characterization of the mouse muscle-specific enolase: developmental changes in electrophoretic variants and selective binding to other proteins.	ENO1 ENO3	2.78e-05	2	184	2	9169614
Pubmed	Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.	ADAM17 ALCAM	2.78e-05	2	184	2	24044434
Pubmed	Fibre-type distribution and subcellular localisation of alpha and beta enolase in mouse striated muscle.	ENO1 ENO3	2.78e-05	2	184	2	11229603
Pubmed	Passenger deletions generate therapeutic vulnerabilities in cancer.	ENO1 ENO2	2.78e-05	2	184	2	22895339
Pubmed	HIV-host interactome revealed directly from infected cells.	CAD COPB2 HHIP KIAA1217 ASPH ADAM17 HSPB1	3.88e-05	172	184	7	27375898
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	NUP88 ITGB4 KIAA1217 CAVIN1 EIF4G3 UTRN	4.08e-05	118	184	6	30979931
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ARID4B CENPC GIT1 ARID4A CHAF1A EDC4 PRC1 TRIP12 LTBP1 CHD6 KDM1B PRDM15 UTRN	4.35e-05	645	184	13	25281560
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SHROOM3 CAD NCKAP1 MBOAT7 LSG1 CHAF1A RBM26 E4F1 EDC4 DHX8 NOMO1 MYOF CELSR1 MDN1 ASPH BRD9 CHD6 KDM1B EIF4G3 UTRN ZC3HAV1	4.80e-05	1497	184	21	31527615
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	HECW1 MBOAT7 RBM26 DVL3 EDC4 AXIN2 NOMO1 GRIP1 COG6 LTBP1 ENO1 HSPB1	4.81e-05	560	184	12	21653829
Pubmed	Defining the membrane proteome of NK cells.	MYO1G ABCC4 DNAJC13 CAD RPLP0 GIT1 MBOAT7 LSG1 RNF213 EDC4 NOMO1 MDN1 FHOD1 MARF1 ADAM17 BRAT1 ENO1 NBR1	5.27e-05	1168	184	18	19946888
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ARID4B ARID4A SPTA1 CHAF1A SPCS2 NUP88 E4F1 TEAD1 PRC1 TRIP12 DHX8 MDN1 ZFP64 ASPH ARID5B CHD6 KDM1B HSPB1 ZC3HAV1	6.18e-05	1294	184	19	30804502
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ARHGAP26 TUT7 COPB2 SPCS2 LMTK2 TRIP12 ITGB4 NPHP3 ARID5B CEP295 ADAM17 TYW1 KDM1B POLK UTRN RAD17 TGS1	6.94e-05	1084	184	17	11544199
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MAN2A2 GIT1 ELP1 TEAD1 NPHP3 ZNF160 ENO1 UTRN ENO3 HSPB1 TGS1	7.49e-05	497	184	11	23414517
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	DNAJC13 NCKAP1 CENPC MBOAT7 LSG1 C1orf43 SPCS2 MICAL2 FHOD1 ASPH ARID5B CAVIN1 ADAM17 ALCAM ZNF160 BRAT1 ENO1 HSPB1	7.67e-05	1203	184	18	29180619
Pubmed	Deficiency of Lipin2 Results in Enhanced NF-κB Signaling and Osteoclast Formation in RAW-D Murine Macrophages.	NFATC1 LPIN2	8.32e-05	3	184	2	33809261
Pubmed	Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.	ENO2 ENO3	8.32e-05	3	184	2	22087329
Pubmed	Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice.	ABCC3 ABCC4	8.32e-05	3	184	2	17273943
Pubmed	Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b.	ABCC3 ABCC4	8.32e-05	3	184	2	25952649
Pubmed	Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.	ABCC3 ABCC4	8.32e-05	3	184	2	15886284
Pubmed	Application of multivariate statistical procedures to identify transcription factors that correlate with MRP2, 3, and 4 mRNA in adult human livers.	ABCC3 ABCC4	8.32e-05	3	184	2	19480556
Pubmed	Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.	ABCC3 ABCC4	8.32e-05	3	184	2	9270026
Pubmed	Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.	TCF19 ALCAM	8.32e-05	3	184	2	9209500
Pubmed	Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.	NFATC1 UTRN	8.32e-05	3	184	2	14681302
Pubmed	Expression of the murine small heat shock proteins hsp 25 and alpha B crystallin in the absence of stress.	CRYAA HSPB1	8.32e-05	3	184	2	8425893
Pubmed	Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.	BTN2A1 BTN2A2	8.32e-05	3	184	2	37356345
Pubmed	RANKL-Induced Btn2a2 - A T Cell Immunomodulatory Molecule - During Osteoclast Differentiation Fine-Tunes Bone Resorption.	BTN2A1 BTN2A2	8.32e-05	3	184	2	34421818
Pubmed	EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts.	GIT1 EPHA2	8.32e-05	3	184	2	19193766
Pubmed	Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.	ARID4B ARID4A	8.32e-05	3	184	2	29797600
Pubmed	Stimulation of DNA synthesis activity of human DNA polymerase kappa by PCNA.	POLL POLK	8.32e-05	3	184	2	11784855
Pubmed	Structural and functional specificity of small heat shock protein HspB1 and HspB4, two cellular partners of HspB5: role of the in vitro hetero-complex formation in chaperone activity.	CRYAA HSPB1	8.32e-05	3	184	2	22210387
Pubmed	Hydroimidazolone modification of the conserved Arg12 in small heat shock proteins: studies on the structure and chaperone function using mutant mimics.	CRYAA HSPB1	8.32e-05	3	184	2	22272318
Pubmed	Cav2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization.	CACNA1B NFATC1	8.32e-05	3	184	2	36137995
Pubmed	ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.	ABCC3 ABCC4	8.32e-05	3	184	2	21799180
Pubmed	ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells.	ABCC3 ABCC4	8.32e-05	3	184	2	19077464
Pubmed	Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides.	ABCC3 ABCC4	8.32e-05	3	184	2	17485564
Pubmed	LMKB/MARF1 localizes to mRNA processing bodies, interacts with Ge-1, and regulates IFI44L gene expression.	EDC4 MARF1	8.32e-05	3	184	2	24755989
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CAD CHAF1A RBM26 NUP88 PRC1 TRIP12 ITGB4 EIF4G3 BRAT1 HSPB1 ZC3HAV1	8.33e-05	503	184	11	16964243
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	CAD COPB2 RNF213 MYOF ENO1 UTRN HSPB1 ZC3HAV1	9.73e-05	268	184	8	33024031
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	RALGAPA1 NCKAP1 GIT1 SPTA1 ARHGAP26 ELP1 GRIP1 CTNNA3 KCNQ2 AGAP6	1.07e-04	430	184	10	32581705
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	DNAJC13 CAD DDX60 TUT7 TRIP12 ITGB4 MYOF	1.07e-04	202	184	7	33005030
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DNAJC13 CAD NCKAP1 CENPC MBOAT7 LSG1 TUT7 COPB2 ELP1 TRIP12 MDN1 MICAL2 FHOD1 ASPH CAVIN1 ENO1 UTRN HSPB1 ZC3HAV1	1.11e-04	1353	184	19	29467282
Interaction	ANKRD20A1 interactions	ANKRD20A2P ANKRD20A4P NFATC1 ANKRD20A1	2.07e-06	11	183	4	int:ANKRD20A1
Interaction	CGAS interactions	DNAJC13 CENPC ARID4A LSG1 DDX60 TUT7 USP25 TEAD1 PRC1 MYOF ASPH HSPB1 ZC3HAV1	1.03e-05	329	183	13	int:CGAS
Interaction	ANKRD20A4P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	1.44e-05	6	183	3	int:ANKRD20A4P
Interaction	ANKRD20A2P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	2.51e-05	7	183	3	int:ANKRD20A2P
GeneFamily	AT-rich interaction domain containing	ARID4B ARID4A ARID5B	1.14e-04	15	117	3	418
GeneFamily	Cavins	CAVIN4 CAVIN1	2.47e-04	4	117	2	1326
GeneFamily	PDZ domain containing	SHROOM3 MAGIX PCLO DVL3 GRIP1 LDB3	4.65e-04	152	117	6	1220
GeneFamily	Ferlin family	MYOF FER1L4	6.12e-04	6	117	2	828
GeneFamily	Ankyrin repeat domain containing	GIT1 ANKRD20A2P ANKRD20A3P ANKRD20A4P ASB10 AGAP6 ANKRD20A1	1.00e-03	242	117	7	403
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	BTN2A1 BTN2A2 ALCAM	2.19e-03	40	117	3	592
GeneFamily	Small heat shock proteins	CRYAA HSPB1	2.20e-03	11	117	2	585
GeneFamily	ATP binding cassette subfamily C	ABCC3 ABCC4	3.09e-03	13	117	2	807
GeneFamily	Fibronectin type III domain containing	LRFN1 TRIM42 INSRR ITGB4 EPHA2	3.86e-03	160	117	5	555
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN2A1 BTN2A2	4.13e-03	15	117	2	458
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP26 DLC1 ARHGAP25	4.15e-03	50	117	3	721
Coexpression	GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP	JADE2 DDX60 VPS8 VSIG10 BTN2A1 NUDT3 SCN3A MARF1 ARHGAP25	1.12e-05	198	183	9	M3249
Coexpression	GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN	RALGAPA1 MAPK8IP1 HECW1 GIT1 SLC30A3 CRYAA DNAI2 ALOX15B CCDC144A	1.21e-05	200	183	9	M5364
Coexpression	XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_345_5P_GENES	TEAD1 ATE1 VSIG10 KCNIP2 TRIP12 EIF4G3	2.09e-05	80	183	6	MM17502
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	DDX60 RNF213 EDC4 HEG1 ARC TSHZ1 ARHGAP25 EIF4G3 UTRN	1.39e-07	198	183	9	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NCKAP1 PCLO TEAD1 ITGB4 MYOF CELSR1 KIAA1217 ALCAM HSPB1	1.51e-07	200	183	9	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP1 PCLO TEAD1 ITGB4 MYOF CELSR1 KIAA1217 ALCAM HSPB1	1.51e-07	200	183	9	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	facs\|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCKAP1 DVL3 TMEM127 HEG1 NUDT3 MARF1 CAVIN1 ENO1	5.61e-07	171	183	8	bb71e816dde44fda6af0ad98d979be9f8740fda6
ToppCell	facs\|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 DVL3 TMEM127 HEG1 NUDT3 MARF1 CAVIN1 ENO1	5.61e-07	171	183	8	5bcb96ed7fc15548f2dc9cf47482f890640cb39c
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM26 DVL3 TMEM127 HEG1 NUDT3 MARF1 CAVIN1 ENO1	5.61e-07	171	183	8	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	COVID-19_Mild-Neu_3\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	ABCC4 TMEM175 ELP1 E4F1 NPHP3 FHOD1 UTRN FCHSD1	6.98e-07	176	183	8	2049767fd591045cfcf5b1071d80798e52843f27
ToppCell	facs\|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 DVL3 ITGB4 HEG1 NUDT3 MARF1 CAVIN1 ENO1	7.93e-07	179	183	8	8001db3044e8657980e24422377c4fdb0d7b323e
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 TEAD1 DLC1 ZFYVE9 MICAL2 ALCAM ARHGEF26 UTRN	9.76e-07	184	183	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 TEAD1 DLC1 ZFYVE9 MICAL2 ALCAM ARHGEF26 UTRN	9.76e-07	184	183	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 MICAL2 SCN3A CTNNA3 LTBP1 UTRN	1.29e-06	191	183	8	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	Control-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	ABCC4 NOMO1 MYOF HEG1 NOMO2 ARC LTBP1 NOMO3	1.34e-06	192	183	8	7e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B HECW1 SLC30A3 CHRNB2 SPHKAP SCN3A KCNQ2 ENO2	1.40e-06	193	183	8	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B HECW1 SLC30A3 CHRNB2 SPHKAP SCN3A KCNQ2 ENO2	1.40e-06	193	183	8	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCC4 SHROOM3 ST7 LMTK2 HHIP DLC1 MICAL2 EPHA2	1.45e-06	194	183	8	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 MICAL2 CTNNA3 CAVIN1 LTBP1 UTRN	1.45e-06	194	183	8	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 MICAL2 CTNNA3 CAVIN1 LTBP1 UTRN	1.45e-06	194	183	8	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 MICAL2 ASB10 SCN3A CAVIN1 LTBP1 UTRN	1.63e-06	197	183	8	aafe279b14cdcb786bc45524bc3c26261128ee48
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 MICAL2 ASB10 SCN3A CAVIN1 LTBP1 UTRN	1.63e-06	197	183	8	fb14da600f563273059a4683a5079af81aca0886
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 MYOF LDB3 DLC1 NFATC1 MICAL2 LTBP1 UTRN	1.63e-06	197	183	8	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCC3 SHROOM3 TMPRSS11E GRIP1 CELSR1 KIAA1217 ALCAM	4.92e-06	162	183	7	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	facs\|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 DVL3 TMEM127 HEG1 NUDT3 MARF1 ENO1	7.29e-06	172	183	7	a2d0a64ebf09d219a07d6bbad1056bad6d46b9be
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHAF1A PRC1 CPED1 MYOF HHIP NETO1 HSPB1	7.29e-06	172	183	7	29c8510f26527d487d0fc3543102d067cdb281a6
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PHF19 WNT8B CAVIN4 CELSR1 C6orf118 ACSM5	7.35e-06	113	183	6	fed408864201218295bac0cc6647953fda8d688e
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PHF19 WNT8B CAVIN4 CELSR1 C6orf118 ACSM5	7.35e-06	113	183	6	c0b8d7a2e3722029e850051bdff77f31f34a8cca
ToppCell	Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap+_astrocytes_(Gfap)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PHF19 WNT8B CAVIN4 CELSR1 C6orf118 ACSM5	7.35e-06	113	183	6	7e24c0f6a80e10a2a41325d48a87628bd330a1e2
ToppCell	facs\|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 DVL3 TMEM127 HEG1 NUDT3 MARF1 ENO1	8.16e-06	175	183	7	53e96956019f984decc1c81376ebc88fbf3c4d40
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 GRIP1 CELSR1 FHOD1 ALCAM ARHGEF26 UTRN	8.79e-06	177	183	7	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	CACNA1B PCLO INSRR PCDHAC1 TEAD1 ARC ALCAM	9.45e-06	179	183	7	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ABCC4 SHROOM3 HHIP DLC1 MICAL2 ASPH ALOX15B	9.80e-06	180	183	7	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	Basal\|World / shred by cell class for mouse tongue	MAN2A2 ITGB4 CELSR1 HEG1 KIAA1217 CAVIN1 LTBP1	1.09e-05	183	183	7	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	ABCC3 SPIRE2 ARHGAP26 ITGB4 SCN3A ASPH MGAM2	1.09e-05	183	183	7	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYCN PCLO NPAS3 SLC30A3 ITGB4 NFATC1 SCN3A	1.17e-05	185	183	7	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC30A3 HHIP LDB3 NETO1 CTNNA3 ENO2 FCHSD1	1.21e-05	186	183	7	aa88d9573a237b2b8e6025fee31f69fbce824497
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 TCP11 VSIG10 ITGB4 EPHA2 DNAI2 ALCAM	1.21e-05	186	183	7	29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e
ToppCell	facs-Lung-EPCAM-18m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC30A3 HHIP LDB3 NETO1 CTNNA3 ENO2 FCHSD1	1.21e-05	186	183	7	ecc5acd111a6ee50d59544d1bdd7ed94e2812aae
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 GRIP1 MYOF CELSR1 LPIN2 ARHGEF26 UTRN	1.21e-05	186	183	7	3aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC30A3 HHIP LDB3 NETO1 CTNNA3 ENO2 FCHSD1	1.21e-05	186	183	7	26458ff8cad5577de4306cffa0ca69eb26940e0d
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC30A3 HHIP LDB3 NETO1 CTNNA3 ENO2 FCHSD1	1.21e-05	186	183	7	a71397efc68d2916ddc373d92cfd07be58033e1c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 MICAL2 ASB10 CTNNA3 LTBP1	1.35e-05	189	183	7	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 MICAL2 ASB10 CTNNA3 LTBP1	1.35e-05	189	183	7	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CPED1 LDB3 DLC1 SPHKAP LPL CTNNA3 LTBP1	1.39e-05	190	183	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 LMTK2 TEAD1 HEG1 DLC1 MICAL2 ARHGEF26	1.39e-05	190	183	7	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYCN HECW1 TCP11 CHAF1A PCLO PRC1	1.43e-05	127	183	6	6b24630978eb0772b4cd3bf59e5bc4390be47619
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	ABCC4 NOMO1 MYOF NOMO2 ARC LTBP1 NOMO3	1.44e-05	191	183	7	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	SHROOM3 TEAD1 HHIP DLC1 MICAL2 KIAA1217 CAVIN1	1.49e-05	192	183	7	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 MICAL2 ASB10 SCN3A CTNNA3 LTBP1	1.49e-05	192	183	7	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 MICAL2 ASB10 SCN3A CTNNA3 LTBP1	1.49e-05	192	183	7	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NPAS3 GRIP1 NETO1 KIAA1217 SPHKAP ADAMTS20 ALCAM	1.54e-05	193	183	7	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	Ionocyte-iono-4\|World / Class top	TMPRSS11E NUP88 KCNIP2 CPED1 KDM1B BRAT1	1.57e-05	129	183	6	85ee6e16959cb58a58f5b09edf1f78d9ce6a9441
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 TEAD1 HHIP DLC1 MICAL2 ALCAM ARHGEF26	1.59e-05	194	183	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 MICAL2 CAVIN1 LTBP1 UTRN	1.59e-05	194	183	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	SHROOM3 NCKAP1 TEAD1 HHIP DLC1 KIAA1217 CAVIN1	1.65e-05	195	183	7	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1B HECW1 SLC30A3 CHRNB2 SCN3A KCNQ2 ENO2	1.65e-05	195	183	7	ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	SHROOM3 NCKAP1 TEAD1 HHIP DLC1 KIAA1217 CAVIN1	1.65e-05	195	183	7	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	SHROOM3 TEAD1 CELSR1 C6orf118 LRRIQ1 KIAA1217 DNAI2	1.70e-05	196	183	7	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 MICAL2 SCN3A CAVIN1 LTBP1 UTRN	1.76e-05	197	183	7	8b3bf5b45e49bf1c60e4d2703b470bb890385f67
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SHROOM3 CPED1 HHIP LTBP1 ALCAM ENO1 HSPB1	1.76e-05	197	183	7	4e0c3ea4f4a04a41532806edf3bccf7845c86fa5
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 MICAL2 SCN3A CAVIN1 LTBP1 UTRN	1.76e-05	197	183	7	02e70768a917c5f097bc653e9e965a1000289d2e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B HECW1 PCLO GRIP1 NETO1 MICAL2 SCN3A	1.82e-05	198	183	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GRIP1 MYOF CELSR1 FHOD1 LPIN2 ARHGEF26 UTRN	1.82e-05	198	183	7	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYCN RPLP0 PDE8B KCNQ2 TSHZ1 CHD6 ENO3	1.82e-05	198	183	7	e442692a8a5aad5b84eabbf051d32eae01b1069a
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYO1G TCF19 KCNIP2 CEP295 CCDC180 FCHSD1	1.86e-05	133	183	6	8ff1cf0ea1fc33fe8384c0e65c1ee1853b25a2ae
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 ST7 CELSR1 MICAL2 KIAA1217 ASPH ALCAM	1.88e-05	199	183	7	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 ST7 HHIP DLC1 MICAL2 ASPH ALCAM	1.88e-05	199	183	7	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 ST7 CELSR1 MICAL2 KIAA1217 ASPH ALCAM	1.88e-05	199	183	7	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF CELSR1 FHOD1 LPIN2 ARC ARHGEF26 UTRN	1.88e-05	199	183	7	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NCKAP1 GIT1 RNF213 HEG1 DLC1 KIAA1217 RGL2	1.94e-05	200	183	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	NS-control-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NCKAP1 TEAD1 ITGB4 MYOF KIAA1217 ALCAM HSPB1	1.94e-05	200	183	7	d014959891893b6d3854a471fba1dc50c6625a0a
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NCKAP1 GIT1 RNF213 HEG1 DLC1 KIAA1217 RGL2	1.94e-05	200	183	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOF CELSR1 FHOD1 LPIN2 ARC ARHGEF26 UTRN	1.94e-05	200	183	7	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 PCLO GRIP1 CELSR1 KIAA1217 ALCAM DOP1B	1.94e-05	200	183	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCKAP1 TMPRSS11E LMTK2 TEAD1 EPHA2 ALCAM HSPB1	1.94e-05	200	183	7	1c02a7f4047d1d2208cc522c6bb4a4989d7845bb
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	NCKAP1 GIT1 HEG1 DLC1 KIAA1217 EIF4G3 RGL2	1.94e-05	200	183	7	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	NCKAP1 GIT1 HEG1 DLC1 KIAA1217 EIF4G3 RGL2	1.94e-05	200	183	7	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	NCKAP1 GIT1 ITGB4 HEG1 LPL ARC LTBP1	1.94e-05	200	183	7	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCKAP1 TMPRSS11E LMTK2 TEAD1 EPHA2 ALCAM HSPB1	1.94e-05	200	183	7	03051d2190244208905e1611019d4b8fd200bae0
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	CPED1 MYOF HHIP LDB3 ARID5B CTNNA3 TSHZ1	1.94e-05	200	183	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	MAN2A2 SLC30A3 AXIN2 MTMR11 ZFP64 FCHSD1	3.95e-05	152	183	6	ca23261d8ef263cc697b8d7e7cb2afec8bc564f2
ToppCell	PND28-Immune-Immune_Myeloid-DC-maDC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G CRYAA ARC POLL ENO2 ENO3	4.10e-05	153	183	6	b03375c54aa701817c0fc2c3fef32b870169e697
ToppCell	PND28-Immune-Immune_Myeloid-DC-maDC-maDC_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO1G CRYAA ARC POLL ENO2 ENO3	4.10e-05	153	183	6	18bd770a18e642581a6df144d47184c1ac383713
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TCP11 CPED1 CHRNB2 DLC1 MICAL2 LTBP1	4.57e-05	156	183	6	d5207dbfbcfb885557ea1378dfe6a56d7102e94a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TCP11 CPED1 CHRNB2 DLC1 MICAL2 LTBP1	4.57e-05	156	183	6	363f1b661048d25895e2b8681c82894c957b29c0
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	MAN2A2 SLC30A3 AXIN2 MTMR11 ZFP64 FCHSD1	5.26e-05	160	183	6	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh\|GI_large-bowel / Manually curated celltypes from each tissue	ARID4B PLXND1 ALPK1 AXIN2 ZFYVE9 CAVIN1	5.84e-05	163	183	6	4104d3b9748b39cb0744c9be76db21bdda566a0d
ToppCell	LA-16._Neuronal\|LA / Chamber and Cluster_Paper	ITGB4 DLC1 KIAA1217 CHP2 ALCAM ARHGEF26	6.90e-05	168	183	6	c55bbfbde8bb954f1cb9af82007bdd1f8070fee3
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	SHROOM3 TEAD1 HEG1 DLC1 ALCAM ARHGEF26	7.37e-05	170	183	6	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RALGAPA1 CENPC RNF213 UTRN CCDC144A ZC3HAV1	7.61e-05	171	183	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TEAD1 DLC1 ANKRD20A4P KIAA1217 ARHGAP25 ANKRD20A1	8.37e-05	174	183	6	99eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX60 CRYAA ALCAM EIF4G3 ENO1 ENO3	8.64e-05	175	183	6	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LDB3 ANKRD20A4P SCN3A CTNNA3 LTBP1 UTRN	8.64e-05	175	183	6	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LDB3 ANKRD20A4P SCN3A CTNNA3 LTBP1 UTRN	8.64e-05	175	183	6	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 MYOF DLC1 NFATC1 MICAL2 LTBP1	8.92e-05	176	183	6	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 MYOF DLC1 NFATC1 MICAL2 LTBP1	8.92e-05	176	183	6	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 CTNNA3 LTBP1 UTRN	9.20e-05	177	183	6	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 BTN2A2 KIAA1217 ARHGEF26 UTRN HSPB1	9.20e-05	177	183	6	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPED1 LDB3 DLC1 CTNNA3 LTBP1 UTRN	9.20e-05	177	183	6	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	TEAD1 VSIG10 SLC30A3 NFATC1 KIAA1217 ARID5B	9.49e-05	178	183	6	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXND1 DLC1 FHOD1 ARID5B CAVIN1 HSPB1	9.49e-05	178	183	6	93ce73f8bcec63ebf86fabb546f88400e8f06465
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLXND1 ITGB4 MYOF HEG1 MICAL2 UTRN	1.01e-04	180	183	6	67c5068b660cd5e727a665cefe3bd5f8ae887221
Drug	N-succinylphenylglycine	ENO1 ENO2 ENO3	5.02e-07	3	182	3	CID000448582
Drug	AC1MOUJL	ENO1 ENO2 ENO3	5.02e-07	3	182	3	CID003400924
Drug	C03356	ENO1 ENO2 ENO3	5.02e-07	3	182	3	CID000439988
Drug	3-bromo-2-(bromomethyl)propionic acid	ENO1 ENO2 ENO3	5.02e-07	3	182	3	CID000318915
Drug	C04309	ENO1 ENO2 ENO3	5.02e-07	3	182	3	CID000440293
Drug	2,3-diketo-1-phosphohexane	ENO1 ENO2 ENO3	5.02e-07	3	182	3	CID000192519
Drug	dimethyl chlorophosphate	ENO1 ENO2 ENO3	2.00e-06	4	182	3	CID000101863
Drug	[2-(oxidoamino)-2-oxoethyl]phosphonic acid	ENO1 ENO2 ENO3	2.00e-06	4	182	3	CID011969443
Drug	3-aminoenolpyruvate-2-phosphate	ENO1 ENO2 ENO3	2.00e-06	4	182	3	CID003037152
Drug	2-ptz	ENO1 ENO2 ENO3	2.00e-06	4	182	3	CID000445375
Drug	tricyclohexylammonium	ENO1 ENO2 ENO3	2.00e-06	4	182	3	CID000226271
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ELP1 CPED1 CELSR1 ZFYVE9 EPHA2 LPIN2 KHK CAVIN1 ADAM17 ALOX15B	4.21e-06	196	182	10	6229_UP
Drug	Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; HL60; HT_HG-U133A	MAGIX PCLO BTN2A1 ZFYVE9 ARID5B POLL ARHGAP25 ADAM17 ENO2 ENO3	4.61e-06	198	182	10	2971_UP
Drug	N-methylacrylamide	ENO1 ENO2 ENO3	4.97e-06	5	182	3	CID000014471
Drug	AC1L1CAI	ENO1 ENO2 ENO3	4.97e-06	5	182	3	CID000000145
Drug	tartronate semialdehyde phosphate	ENO1 ENO2 ENO3	4.97e-06	5	182	3	CID000151938
Drug	2-phospho-3-butenoic acid	ENO1 ENO2 ENO3	4.97e-06	5	182	3	CID000191423
Drug	1-Pdmsp	ENO1 ENO2 ENO3	4.97e-06	5	182	3	CID000000561
Drug	1 IN	ARHGAP26 ENO1 ENO2 ENO3	5.03e-06	15	182	4	CID000449311
Drug	dimidium	ENO1 ENO2 ENO3	9.87e-06	6	182	3	CID000068207
Drug	Z(2-Cl)-OSu	ENO1 ENO2 ENO3	9.87e-06	6	182	3	CID000580665
Drug	4-(N,N-dimethylamino)cinnamoyl-CoA	ENO1 ENO2 ENO3	9.87e-06	6	182	3	CID000445461
Drug	N-tert-butylacrylamide	ENO1 ENO2 ENO3	1.72e-05	7	182	3	CID000007877
Drug	glycidol phosphate	ENO1 ENO2 ENO3	1.72e-05	7	182	3	CID000152659
Drug	lavendustin C6	ENO1 ENO2 ENO3	1.72e-05	7	182	3	CID000126839
Drug	CPEP	ENO1 ENO2 ENO3	1.72e-05	7	182	3	CID000360637
Drug	macrophomate	ENO1 ENO2 ENO3	2.73e-05	8	182	3	CID010889109
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A	HECW1 PCLO NPAS3 DLC1 ZFYVE9 RNF6 ALCAM ZNF160 MASP2	2.97e-05	196	182	9	2263_UP
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	HECW1 SPTA1 DVL3 CRYAA DLC1 PDE8B ARC CAVIN1 UTRN	2.97e-05	196	182	9	2296_UP
Drug	Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	PCLO WNT8B NPAS3 ZFYVE9 NFATC1 ZFP64 DNAI2 POLL ALOX15B	3.09e-05	197	182	9	3978_UP
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A	ABCC3 ARHGAP26 ELP1 SLC30A3 CPED1 BTN2A2 DNAI2 CAVIN1 ARHGEF26	3.21e-05	198	182	9	2647_UP
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A	HECW1 ARHGAP26 ALPK1 ASIC3 CHRNB2 BTN2A2 MICAL2 LPIN2 ALCAM	3.21e-05	198	182	9	5944_UP
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; PC3; HG-U133A	NCKAP1 ST7 PLXND1 TEAD1 BTN2A1 CHRNB2 ASPH LTBP1 EIF4G3	3.21e-05	198	182	9	1908_DN
Drug	Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A	ABCC3 HECW1 TCP11 SPTA1 NPAS3 ALPK1 DLC1 MICAL2 ZFP64	3.47e-05	200	182	9	4481_UP
Drug	Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A	ABCC3 HECW1 LMTK2 BTN2A2 LDB3 MICAL2 ZFP64 ARC KHK	3.47e-05	200	182	9	3619_UP
Drug	AC1L19IJ	ENO1 ENO2 ENO3	4.07e-05	9	182	3	CID000000562
Drug	AC1L1A4W	ENO1 ENO2 ENO3	4.07e-05	9	182	3	CID000000837
Drug	pyrene-4,5-dione	ENO1 ENO2 ENO3	5.79e-05	10	182	3	CID000160814
Drug	L-fuconic acid	ENO1 ENO2 ENO3	5.79e-05	10	182	3	CID000345732
Drug	HAVA	MYCN NETO1 ENO2	5.79e-05	10	182	3	CID000170929
Drug	phosphoenolthiopyruvate	ENO1 ENO2 ENO3	5.79e-05	10	182	3	CID000194910
Drug	xylonate	ENO1 ENO2 ENO3	5.79e-05	10	182	3	CID000010264
Drug	beta-ketoadipate	TSHZ1 ENO1 ENO2 ENO3 ALOX15B	6.50e-05	53	182	5	CID000000093
Drug	carboplatin	MYCN MAPK8IP1 ABCC3 ABCC4 SRRD ADAM17 ENO2	9.01e-05	131	182	7	CID000038904
Drug	reductone	NETO1 ENO1 ENO2 ENO3	9.20e-05	30	182	4	CID003034155
Drug	LG61	ENO1 ENO2 ENO3	1.05e-04	12	182	3	CID000520177
Drug	AC1L18ZV	ENO1 ENO2 ENO3	1.05e-04	12	182	3	CID000000329
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; PC3; HT_HG-U133A	MAN2A2 ARHGAP26 LMTK2 PLXND1 KCNIP2 CHRNB2 LDB3 LPL	1.62e-04	192	182	8	6734_UP
Drug	B-43	ENO1 ENO2 ENO3	1.71e-04	14	182	3	CID006603792
Drug	Hecameg	ENO1 ENO2 ENO3	1.71e-04	14	182	3	CID002733955
Drug	Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A	ABCC3 PCLO ITGB4 FGF23 ZFYVE9 ZFP64 POLL MASP2	1.80e-04	195	182	8	5385_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A	TUT7 DVL3 ASIC3 FGF23 POLL CAVIN1 ALCAM UTRN	1.86e-04	196	182	8	6846_DN
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; MCF7; HT_HG-U133A	GIT1 MBOAT7 ST7 MTMR11 EPHA2 CAVIN1 ADAM17 ALCAM	1.86e-04	196	182	8	7348_DN
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A	ALPK1 MYOF ZFYVE9 ARC POLL LTBP1 ADAM17 UTRN	1.86e-04	196	182	8	2280_DN
Drug	cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A	LMTK2 ALPK1 ASIC3 LDB3 NFATC1 DNAI2 CTNNA3 MASP2	1.86e-04	196	182	8	253_UP
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	GIT1 ALPK1 HEG1 EPHA2 ASPH ALCAM ZNF160 ZC3HAV1	1.86e-04	196	182	8	5020_DN
Drug	Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A	ELP1 ALPK1 MYOF PDE8B CAVIN1 ARHGEF26 ENO2 ZC3HAV1	1.86e-04	196	182	8	6269_UP
Drug	harmol glucuronide	ABCC3 ABCC4	1.90e-04	3	182	2	CID005488285
Drug	E 4021	PDE8A PDE8B	1.90e-04	3	182	2	ctd:C091517
Drug	Sb 204990	NETO1 LPL	1.90e-04	3	182	2	CID000132975
Drug	Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	ALPK1 CHRNB2 ASPH DNAI2 ARC ACSM5 ARHGEF26 ENO3	1.93e-04	197	182	8	4566_UP
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	ABCC3 MAN2A2 PCLO WNT8B BTN2A2 HEG1 DLC1 ARC	1.93e-04	197	182	8	6412_DN
Drug	Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A	DVL3 ELP1 ASIC3 FGF23 PDE8B ZFP64 ASPH CAVIN1	1.93e-04	197	182	8	4160_DN
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; HL60; HT_HG-U133A	GIT1 ALPK1 ITGB4 ZFYVE9 ASPH POLL ENO3 DOP1B	1.93e-04	197	182	8	2149_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	MAN2A2 GIT1 DVL3 ELP1 ITGB4 ASPH CAVIN1 TGS1	1.93e-04	197	182	8	3309_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	HECW1 GIT1 MBOAT7 PCLO DVL3 ZFP64 ARC UTRN	2.00e-04	198	182	8	5427_UP
Drug	Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A	MAN2A2 ALPK1 FGF23 MYOF HEG1 KHK CAVIN1 UTRN	2.00e-04	198	182	8	3900_DN
Drug	Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	CHRNB2 FGF23 BTN2A2 DNAI2 KHK ALCAM ENO1 ENO3	2.07e-04	199	182	8	2744_UP
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A	ABCC3 ELP1 EDC4 ITGB4 EPHA2 ASPH ENO2 TGS1	2.07e-04	199	182	8	2802_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A	ABCC3 SLC30A3 FGF23 BTN2A2 DLC1 ASPH LPIN2 CAVIN1	2.07e-04	199	182	8	5201_UP
Disease	Down syndrome (biomarker_via_orthology)	RPLP0 RPLP0P6	3.54e-05	2	176	2	DOID:14250 (biomarker_via_orthology)
Disease	intraocular pressure measurement	ST7 PCLO NPAS3 MYOF LDB3 NPHP3 DLC1 ARID5B ADAMTS20 LTBP1 ALCAM	2.57e-04	509	176	11	EFO_0004695
Disease	Adenoid Cystic Carcinoma	MYCN ARID4B INSRR ITGB4 ARID5B	3.40e-04	100	176	5	C0010606
Disease	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2	LDB3 CTNNA3	3.50e-04	5	176	2	C1832931
Disease	vital capacity	SHROOM3 JADE2 TCP11 ARHGAP26 PCLO PCDHAC1 TEAD1 ATE1 TRIP12 CAVIN4 HHIP MTMR11 CCNYL1 LRRIQ1 ARID5B CTNNA3 LTBP1 UTRN	4.50e-04	1236	176	18	EFO_0004312
Disease	body surface area	RALGAPA1 ARHGAP26 E4F1 TEAD1 CPED1 TRIP12 AXIN2 HHIP MTMR11 DLC1 LTBP1 ARHGEF26	5.09e-04	643	176	12	EFO_0022196
Disease	metabolite measurement	ABCC3 ABCC4 MBOAT7 SPTA1 TMPRSS11E UBL4A MYOF MICAL2 LPL KHK ALCAM	5.72e-04	560	176	11	EFO_0004725
Disease	Headache	RNF213 FGF23 BTN2A2 GPR149	5.88e-04	64	176	4	HP_0002315
Disease	magnesium measurement	SHROOM3 ALPK1 ATE1 DLC1	6.61e-04	66	176	4	EFO_0004845
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	MYOF FER1L4	7.28e-04	7	176	2	DOID:11724 (implicated_via_orthology)
Disease	Abnormality of refraction	DNAJC13 PHF19 PCLO PCDHAC1 AXIN2 HHIP LDB3 DLC1 NFATC1 FER1L4 ADAMTS20 UTRN	7.58e-04	673	176	12	HP_0000539
Disease	nose morphology measurement	TRIM42 VSIG10 AXIN2 DLC1 MICAL2 ARID5B TYW1 RPE65	8.45e-04	329	176	8	EFO_0007843
Disease	Hereditary spherocytosis	CAD SPTA1	9.67e-04	8	176	2	C0037889
Disease	pseudouridine measurement	SHROOM3 PDE8A	9.67e-04	8	176	2	EFO_0021126
Disease	pantothenate measurement	CAD SLC30A3	9.67e-04	8	176	2	EFO_0021034
Disease	Parkinson's disease (implicated_via_orthology)	HIPK4 INSRR SPCS2 AXIN2 EIF4G3	2.56e-03	157	176	5	DOID:14330 (implicated_via_orthology)
Disease	cortical thickness	SHROOM3 SPIRE2 PDE8A CHAF1A PLXND1 CPED1 KIAA1614 GRIP1 HHIP CELSR1 DLC1 LRRIQ1 ADAMTS20 ALCAM EIF4G3	2.85e-03	1113	176	15	EFO_0004840
Disease	cortical surface area measurement	SHROOM3 SPIRE2 DNAJC13 PDE8A CHAF1A TUT7 NPAS3 PLXND1 CPED1 KIAA1614 GRIP1 HHIP CELSR1 MTMR11 LRRIQ1 ADAMTS20 ALCAM	2.93e-03	1345	176	17	EFO_0010736
Disease	diverticular disease	HECW1 ATE1 HHIP DLC1 KIAA1217 LTBP1	3.01e-03	236	176	6	EFO_0009959
Disease	complement factor H-related protein 3 measurement	TMPRSS11E NFATC1 ASPH ARID5B KCNQ2	3.52e-03	169	176	5	EFO_0600056
Disease	total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement	SLC30A3 LPL POLK	3.52e-03	51	176	3	EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
Disease	lysophosphatidylcholine 14:0 measurement	CAD SLC30A3	3.53e-03	15	176	2	EFO_0010356
Disease	body weight	RALGAPA1 CACNA1B JADE2 NUP88 E4F1 TEAD1 TRIP12 AXIN2 HHIP BTN2A2 NUDT3 KIAA1217 SPHKAP CTNNA3 LTBP1 ARHGEF26	3.74e-03	1261	176	16	EFO_0004338
Disease	Congenital total cataract	CRYAA EPHA2	4.02e-03	16	176	2	C0266539
Disease	Schizoaffective disorder-bipolar type	MYO1G PCLO	4.02e-03	16	176	2	EFO_0009965
Disease	phosphatidylcholine 38:6 measurement	ABCC3 LTBP1	4.02e-03	16	176	2	EFO_0010388
Disease	serum metabolite measurement	RALGAPA1 ABCC4 PDE8A MBOAT7 TMPRSS11E TEAD1 CPED1 NFATC1 LPL ARID5B ALCAM CCDC180 CCDC63	4.53e-03	945	176	13	EFO_0005653
Disease	factor VIII measurement, coronary artery disease	ARHGAP26 BTN2A1 GPR149 LPL	4.75e-03	113	176	4	EFO_0001645, EFO_0004630
Disease	factor XI measurement, coronary artery disease	ARHGAP26 GPR149 LPL ZNF160	5.06e-03	115	176	4	EFO_0001645, EFO_0004694
Disease	Nuclear non-senile cataract	CRYAA EPHA2	5.08e-03	18	176	2	C1112705
Disease	Nuclear cataract	CRYAA EPHA2	5.08e-03	18	176	2	C0392557
Disease	tropical spastic paraparesis	TCF19 BTN2A1	5.08e-03	18	176	2	EFO_0007527
Disease	3-hydroxypropylmercapturic acid measurement	NPAS3 NFATC1 KIAA1217 LPL CHP2 ADAMTS20 HSPB1	5.36e-03	352	176	7	EFO_0007014
Disease	peripheral neuropathy, response to docetaxel trihydrate	SPHKAP CTNNA3	5.66e-03	19	176	2	EFO_0003100, GO_1902519
Disease	corneal resistance factor	MYOF NPHP3 ARID5B ADAMTS20 LTBP1 ALCAM BRAT1 MASP2	5.87e-03	451	176	8	EFO_0010067

Protein segments in the cluster

Peptide	Gene	Start	Entry
IFHELRVDSLPASDD	ANKRD20A1	276	Q5TYW2
ERHFAESETLDQLPL	ARID4B	111	Q4LE39
TSPEHAEARQSLFLE	BRAT1	581	Q6PJG6
ERHFAESETLDQLPL	ARID4A	111	P29374
IFHELRVDSLPASDD	ANKRD20A8P	276	Q5CZ79
SPDVHALLEITEESD	CAVIN1	366	Q6NZI2
PDILSDDERRSVAHV	CATSPERE	276	Q5SY80
LAPHETIFRAEDLSV	CPED1	256	A4D0V7
ADEEETHPVDLSSLS	BRD9	346	Q9H8M2
TVSTDPEHRFELALQ	COPB2	636	P35606
IFHELRVDSLPASDD	ANKRD20A4P	276	Q4UJ75
TQIFEDPREFLSHLE	ARC	211	Q7LC44
SEEEEETPLHVAARL	ASB10	211	Q8WXI3
IFVVDSADHSRLPEA	ARL9	91	Q6T311
PALSSSEDEVDVLLH	EAPP	21	Q56P03
YEEDPQTILDDHLSR	AXIN2	431	Q9Y2T1
EVESALAEHPAVLES	ACSM5	486	Q6NUN0
ELTTRLQPFHSTELE	GIT1	526	Q9Y2X7
PSFKEVLSRIESHED	ARHGEF26	551	Q96DR7
DVDDRFETLEPEVSH	ASPH	191	Q12797
PDSDRTSEVYLHEEL	CCDC144CP	431	Q8IYA2
FDTIHEEFPRELESS	CELSR1	2266	Q9NYQ6
DASSDVPERVFHLSA	DNHD1	4571	Q96M86
SEELELRHQSLDAFP	CCDC180	16	Q9P1Z9
VLESFPEEDSVLSHS	CHAF1A	271	Q13111
LVAELSTIESSHRDP	DNAI2	251	Q9GZS0
ITSSIPDTERLDDFH	DVL3	391	Q92997
ISELYSDELSEPEHE	CAVIN4	306	Q5BKX8
SEASVHALPEDTLTF	CACNA1B	2266	Q00975
HALPEDTLTFEEAVA	CACNA1B	2271	Q00975
SLDIFDERSHPLTRE	CCNYL1	161	Q8N7R7
HRSGETEDTFIADLV	ENO2	371	P09104
VLEDTECHEASRPSD	ADAMTS20	1111	P59510
TAESTEDAPLDFHRV	ALPK1	791	Q96QP1
DADRTLSIPDEQLHS	AGAP6	156	Q5VW22
DHISESVPVLELFSN	POLL	326	Q9UGP5
VDHRPRALEISAFTE	RBM26	886	Q5T8P6
SAFTESDREDLLPHF	RBM26	896	Q5T8P6
DIDEIEEVPTTSHRL	NETO1	491	Q8TDF5
TFDVAPSRLDFTVEH	NOMO3	301	P69849
PSRLDFTVEHDSLKI	NOMO3	306	P69849
SHLSEYERDTLLVEP	RAD17	421	O75943
ESSPTVALLHEDRAE	EDC4	251	Q6P2E9
IFLLDDPLSAVDSHV	ABCC3	771	O15438
IFHELRVDSLPASDD	ANKRD20A2P	276	Q5SQ80
DVLAEPLSSERHEFV	MMADHC	101	Q9H3L0
TFDVAPSRLDFTVEH	NOMO2	301	Q5JPE7
PSRLDFTVEHDSLKI	NOMO2	306	Q5JPE7
VELHFDELPSSELET	MDN1	1216	Q9NU22
DDESHFSEILLRASE	MAGEB16	146	A2A368
DSADIEVTDSRLPHA	MAGIX	71	Q9H6Y5
DEEALRRSSTPIEHA	LDB3	291	O75112
AEISHSESEHLPARD	LSG1	276	Q9H089
TVVRPLLHEFTDDRT	MGAM2	1586	Q2M2H8
SRLTFPDREALAEHA	HIPK4	301	Q8NE63
ALHDSVRVPDTLTFL	MTMR11	461	A4FU01
PNFRLTHDISLEEFE	MAPK8IP1	31	Q9UQF2
EITSSIHPDDEEISL	HECW1	341	Q76N89
LTREDDLETCATPEH	LRFN1	266	Q9P244
EEHLPLSQFTTVDRE	DOP1B	1051	Q9Y3R5
ESPNFTELVRHLTVD	FER1L4	981	A9Z1Z3
SPSHVRFEDESAREA	KIAA1614	446	Q5VZ46
FDDDLLRLETPNHVT	DDX60	1596	Q8IY21
AERPKVSLHFDTETD	JADE2	736	Q9NQC1
SSSFIIPESHEIVDL	PCLO	2031	Q9Y6V0
SLEDHRFENTPEIAI	PLXND1	226	Q9Y4D7
TSISIPSVDHEELER	KCNQ2	786	O43526
SVSLRFDLHLAATDE	KRT222	246	Q8N1A0
FALRTPEDTAEDTCH	LPL	41	P06858
SRLSPDDADFVDVLH	LPL	196	P06858
AKEEPVEALTFSREH	LTBP1	776	Q14766
AEDEVSSRAKESLPH	OR2W5P	226	A6NFC9
EEEVLLVSSSRHPDR	NUDT3	31	O95989
SIHISERLVAEDAPS	PDE8A	6	O60658
RVSDDHEEASVLPLL	PDE8B	216	O95263
SVDDEFELSTVCHRP	KCNIP2	76	Q9NS61
FHDVEVEDVLPSSKR	NFATC1	136	O95644
TFDVAPSRLDFTVEH	NOMO1	301	Q15155
PSRLDFTVEHDSLKI	NOMO1	306	Q15155
LLSSHLFPLEAVRED	MBOAT7	206	Q96N66
PVEILSTDARTHSLD	LMTK2	866	Q8IWU2
TPDSLESVDVHEALL	LMTK2	996	Q8IWU2
EDVFLAVSHSEFSPR	ELP1	511	O95163
RVSLDVNHFAPDELT	HSPB1	96	P04792
LDERESHRLIFPAVT	ASIC3	76	Q9UHC3
ESLHLPSSSSEFDER	HEG1	206	Q9ULI3
PEVLDITEETLHSRF	RPLP0	201	P05388
HSTTIIIRDPDELDR	ITGB4	1096	P16144
DSDTDSVELPESVLH	LRRIQ1	41	Q96JM4
VSSIEDFKDHIPRET	NCKAP1	936	Q9Y2A7
TFSEGPERRLSHEES	GPR149	506	Q86SP6
TDVNDHAPELDFLTL	PCDHAC1	331	Q9H158
PLSAVDAEVSRHLFE	ABCC4	561	O15439
ALVSELSEHLRDPLT	FCHSD1	236	Q86WN1
RDPLTSLSHTELEAA	FCHSD1	246	Q86WN1
EVLASHDSSVVPLDA	COG6	451	Q9Y2V7
IIDHVSDSFLDTTVP	CTNNA3	381	Q9UI47
HRSGETEDTFIADLV	ENO1	371	P06733
IFHELRVDSLPASDD	ANKRD20A3P	276	Q5VUR7
TSDHCSLPEDLRVLE	KDM1B	181	Q8NB78
ALDAIRTSEIPFHSE	C1orf43	106	Q9BWL3
DRLDDVEQPLDHSSL	CCDC63	511	Q8NA47
HDEISRCSLSEPLES	CENPC	606	Q03188
ESRDDHLSLPDVTCE	CHD6	1666	Q8TD26
AILVSEFSHPRELAS	FUT10	321	Q6P4F1
APDEITVSSDFEARH	EPHA2	146	P29317
RHTRSAEDDSERDPL	FGF23	176	Q9GZV9
PDSDRTSEVYLHEEL	CCDC144B	481	Q3MJ40
ASLSHTSEEDFLPVE	C6orf118	136	Q5T5N4
TAHPDLFLSEDRRSV	BTN2A1	336	Q7KYR7
DEEVESLHLRFLATP	DNAJC13	351	O75165
PSHTEQELLRLTDDS	MARF1	1606	Q9Y4F3
DDTRLSHDALPERTV	MAN2A2	626	P49641
DFVESFDVETHPETL	MASP2	226	O00187
RPSFTHILDSIQEEL	INSRR	1236	P14616
DEDRSTEPDRLQVFH	ATE1	461	O95260
IHSPSDFELTEEEAE	FOXR2	146	Q6PJQ5
VLHDTSLPDVSATDF	KHK	111	P50053
HRSGETEDTFIADLV	ENO3	371	P13929
LTEDPHTVLVEFSSV	E4F1	621	Q66K89
DATHAERAIPVSREE	CRYAA	151	P02489
SLDPVSVDTARLEHL	FHOD1	656	Q9Y613
PDSDRTSEVYLHEEL	CCDC144A	481	A2RUR9
FPISSHLSDLGDVEE	GRIP1	766	Q9Y3R0
RTFLHAADVVLDPDT	BTN2A2	321	Q8WVV5
QHADLPSIFSIEARD	CEP295	2186	Q9C0D2
SAISIPEHDEADEIS	ALCAM	501	Q13740
ELEAASAPEERTRLH	EIF4G3	861	O43432
THLSLVSAPEVEDDS	DHX8	371	Q14562
RAEFLPTDHSLSEFE	MICAL2	201	O94851
PTDHSLSEFEFDVII	MICAL2	206	O94851
SFHSELPVLSDSERD	NUP88	646	Q99567
EHFTEEAPRRSIATF	ALOX15B	626	O15296
EHVRDSIDFPEFTDI	GARIN2	226	Q8N9W8
ELLETTREHRSAEAP	REXO1	111	Q8N1G1
EALESLESVLRHPAD	UTRN	1271	P46939
PEVLDKTEETLHSRF	RPLP0P6	201	Q8NHW5
LEALESHPTDELERT	RGL2	141	O15211
SHPTDELERTTEVAI	RGL2	146	O15211
FETVEELSSPLTAHV	RPE65	16	Q16518
IHSDSLDTRDVPEAE	SPHKAP	1481	Q2M3C7
PLDFVELSSAIHELF	TRIM42	476	Q8IWZ5
ETVIRSLTLDAAPDH	NBR1	651	Q14596
ADHPYTARELEALAT	NPHP3	1021	Q7Z494
IDDLDHLPETTTIDA	PRDM15	1256	P57071
EALDHTPDTSFERDV	PRC1	186	O43663
LLFDRPEEAVHEDSS	ARHGAP26	741	Q9UNA1
RDSEVPRESSHEDSL	RNF6	96	Q9Y252
PVEHLSETSADSLEA	KIAA1217	136	Q5T5P2
EETKAHIRFSESAEP	SHROOM3	826	Q8TF72
RSPSALAIEVFEAHL	NPAS3	136	Q8IXF0
FEFLIRLHSAEASPE	VPS8	756	Q8N3P4
FEDSESRRDSLFVPH	SCN3A	601	Q9NY46
ETADRELLPSFHEVS	ST7	491	Q9NRC1
HLDVDNDRTTPSDLD	DLC1	951	Q96QB1
SLFHSPEREVLERDL	HHIP	121	Q96QV1
TDTEERLVEHLLDPS	CHRNB2	26	P17787
SFEDLTDHPVTRSEK	ADAM17	791	P78536
RDTFDHPTLIENESI	ARID5B	226	Q14865
VLAHFRPVEDEDTET	CHP2	86	O43745
SVHRVLAELDDESEP	TCF19	226	Q9Y242
LICRFHSTEDPETVD	TMPRSS11E	121	Q9UL52
DASSPDEFHRDLSHI	RNF213	651	Q63HN8
ITKSLLEDFHSRPEE	TCP11	361	Q8WWU5
LEDFHSRPEEAILTV	TCP11	366	Q8WWU5
ISTRELVHLEDSPDY	WNT8B	241	Q93098
HLLHDPETSSEEDLR	SPATA31D3	781	P0C874
VVLERHESPDIEDFS	ZNF160	116	Q9HCG1
DLHEPLSKERVEAFS	TMEM175	251	Q9BSA9
HSVLQTPDDLEISEF	RALGAPA1	1026	Q6GYQ0
DLRSSFLTLRDHVPE	MYCN	396	P04198
DAYEPEISRLHDSLA	SPCS2	206	Q15005
EFSHPVESLALTVEE	SPIRE2	526	Q8WWL2
SFDRDTDVHTVASLL	ARHGAP25	221	P42331
LSEHERSISPLLFEE	POLK	241	Q9UBT6
APRHITEEELSVLES	USP25	536	Q9UHP3
ERPDEGIDSHTFESI	PHF19	511	Q5T6S3
LHLDSLPEESDVATD	SRRD	111	Q9UH36
AERLSESHPDATEDL	SPTA1	1246	P02549
REELSALVAPAFAHT	CAD	571	P27708
HLAIDSTADPEAVLA	SLC30A3	336	Q99726
ERLASRFLHPEVTET	UBL4A	136	P11441
AEPRFSLVDATSLHI	VSIG10	76	Q8N0Z9
HRASLEDAPVDDLTR	ZC3HAV1	281	Q7Z2W4
LHHRDTEEEEPFESS	TYW1	281	Q9NV66
NHSYSDPLLESVDIR	TEAD1	246	P28347
RSHELDIDENPASDF	TGS1	426	Q96RS0
DFSPTIIEDQAREHI	TUT7	1011	Q5VYS8
TSLTSHDLFDIDPVV	TRIP12	1731	Q14669
RSHTASELDDDVPKA	ZFP64	251	Q9NTW7
TAANLLRHYPTEEEE	TMEM127	191	O75204
SFEEALDELSPVHKR	TSHZ1	871	Q6ZSZ6
VFSLAHSAPLTTEEE	ZFYVE9	71	O95405
THFRVIPSEDNLISE	LPIN2	296	Q92539
ALVDHVAELTATPRD	MYO1G	306	B0I1T2
ERSLLTEADAGHTEF	MYOF	916	Q9NZM1